Elbasvir/Grazoprevir for HCV Infection in Russia: A Randomized Trial

PURPOSE: Hepatitis C virus (HCV) infection is a major healthcare concern in Russia, where almost 5 million individuals are viremic. Elbasvir/grazoprevir is a fixed-dose combination therapy for the treatment of HCV genotype 1 and genotype 4 infection. The present analysis aimed to assess the safety a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhdanov, Konstantin, Isakov, Vasily, Burnevich, Eduard, Kizhlo, Svetlana, Bakulin, Igor, Pokrovsky, Vadim, Liang, Liwen, Hwang, Peggy, Talwani, Rohit, Haber, Barbara A, Robertson, Michael N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183329/
https://www.ncbi.nlm.nih.gov/pubmed/32368162
http://dx.doi.org/10.2147/HMER.S241418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183329/
https://www.ncbi.nlm.nih.gov/pubmed/32368162
http://dx.doi.org/10.2147/HMER.S241418

Ejemplares similares